Randomized phase II study of concurrent cisplatin/etoposide or paclitaxel/carboplatin and thoracic radiotherapy in patients with stage III non-small cell lung cancer

Lung Cancer, 03/15/2012

Compared to cisplatin/etoposide (PE) regimen, weekly paclitaxel/carboplatin (PC) regimen cannot be recommended since it failed to achieve an improvement in either OS or PFS.

Print Article Summary Cat 2 CME Report